Logo image of REBN

REBORN COFFEE INC (REBN) Stock Fundamental Analysis

NASDAQ:REBN - Nasdaq - US75618M3051 - Common Stock - Currency: USD

2.5  +0.01 (+0.4%)

Fundamental Rating

2

REBN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 41 industry peers in the Consumer Staples Distribution & Retail industry. REBN has a bad profitability rating. Also its financial health evaluation is rather negative. REBN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year REBN has reported negative net income.
REBN had a negative operating cash flow in the past year.
REBN had negative earnings in each of the past 5 years.
In the past 5 years REBN always reported negative operating cash flow.
REBN Yearly Net Income VS EBIT VS OCF VS FCFREBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

The Return On Assets of REBN (-61.70%) is worse than 97.56% of its industry peers.
REBN has a Return On Equity of -184.65%. This is amonst the worse of the industry: REBN underperforms 92.68% of its industry peers.
Industry RankSector Rank
ROA -61.7%
ROE -184.65%
ROIC N/A
ROA(3y)-49.38%
ROA(5y)-56.98%
ROE(3y)-173.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REBN Yearly ROA, ROE, ROICREBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

REBN has a better Gross Margin (62.82%) than 97.56% of its industry peers.
REBN's Gross Margin has been stable in the last couple of years.
REBN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.17%
GM growth 5YN/A
REBN Yearly Profit, Operating, Gross MarginsREBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

REBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REBN has more shares outstanding
The debt/assets ratio for REBN has been reduced compared to a year ago.
REBN Yearly Shares OutstandingREBN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M 4M
REBN Yearly Total Debt VS Total AssetsREBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

REBN has an Altman-Z score of -3.84. This is a bad value and indicates that REBN is not financially healthy and even has some risk of bankruptcy.
REBN's Altman-Z score of -3.84 is on the low side compared to the rest of the industry. REBN is outperformed by 95.12% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that REBN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.35, REBN is in line with its industry, outperforming 58.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z -3.84
ROIC/WACCN/A
WACC9.24%
REBN Yearly LT Debt VS Equity VS FCFREBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 0.31 indicates that REBN may have some problems paying its short term obligations.
With a Current ratio value of 0.31, REBN is not doing good in the industry: 95.12% of the companies in the same industry are doing better.
A Quick Ratio of 0.25 indicates that REBN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.25, REBN is doing worse than 78.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.25
REBN Yearly Current Assets VS Current LiabilitesREBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

6

3. Growth

3.1 Past

REBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.87%, which is quite impressive.
REBN shows a decrease in Revenue. In the last year, the revenue decreased by -0.43%.
REBN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.51% yearly.
EPS 1Y (TTM)29.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.75%
Revenue 1Y (TTM)-0.43%
Revenue growth 3Y37.51%
Revenue growth 5YN/A
Sales Q2Q%-1.11%

3.2 Future

REBN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 126.37% yearly.
REBN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 52.11% yearly.
EPS Next Y260%
EPS Next 2Y164.58%
EPS Next 3Y126.37%
EPS Next 5YN/A
Revenue Next Year64.55%
Revenue Next 2Y57.31%
Revenue Next 3Y52.11%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
REBN Yearly Revenue VS EstimatesREBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
REBN Yearly EPS VS EstimatesREBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

REBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
REBN is valuated quite expensively with a Price/Forward Earnings ratio of 30.64.
The rest of the industry has a similar Price/Forward Earnings ratio as REBN.
The average S&P500 Price/Forward Earnings ratio is at 22.41. REBN is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 30.64
REBN Price Earnings VS Forward Price EarningsREBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REBN Per share dataREBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

REBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as REBN's earnings are expected to grow with 126.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y164.58%
EPS Next 3Y126.37%

More info and screens

0

5. Dividend

5.1 Amount

REBN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REBORN COFFEE INC

NASDAQ:REBN (6/17/2025, 9:38:38 AM)

2.5

+0.01 (+0.4%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-14 2022-11-14/amc
Earnings (Next)N/A N/A
Inst Owners1.7%
Inst Owner Change0.85%
Ins Owners35.25%
Ins Owner Change-0.73%
Market Cap13.25M
Analysts82.86
Price TargetN/A
Short Float %0.27%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.64
P/S 2.23
P/FCF N/A
P/OCF N/A
P/B 5.09
P/tB 5.09
EV/EBITDA N/A
EPS(TTM)-1.73
EYN/A
EPS(NY)0.08
Fwd EY3.26%
FCF(TTM)-0.86
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS1.12
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.7%
ROE -184.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.82%
FCFM N/A
ROA(3y)-49.38%
ROA(5y)-56.98%
ROE(3y)-173.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.17%
GM growth 5YN/A
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 283.52%
Cap/Sales 18.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.25
Altman-Z -3.84
F-Score3
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)332.07%
Cap/Depr(5y)258.1%
Cap/Sales(3y)18.95%
Cap/Sales(5y)17.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.75%
EPS Next Y260%
EPS Next 2Y164.58%
EPS Next 3Y126.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.43%
Revenue growth 3Y37.51%
Revenue growth 5YN/A
Sales Q2Q%-1.11%
Revenue Next Year64.55%
Revenue Next 2Y57.31%
Revenue Next 3Y52.11%
Revenue Next 5YN/A
EBIT growth 1Y-19.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year684.52%
EBIT Next 3Y187.41%
EBIT Next 5YN/A
FCF growth 1Y-19.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.69%
OCF growth 3YN/A
OCF growth 5YN/A